A New Horizon for Troubled Sinuses: Unpacking Dupilumab's Promise in Allergic Fungal Rhinosinusitis
Lyra Therapeutics Gambles on Higher Dose in New Phase 3 Trial Following Previous Setback for Chronic Rhinosinusitis Treatment